hatch-waxman-act

5 cases — ← All topics

Case Title Lower Court Docketed Status Flags Tags Question Presented
24-889 Hikma Pharmaceuticals USA Inc., et al. v. Amarin Pharma, Inc., et al. Federal Circuit 2025-02-19 Granted CVSGAmici (5)Relisted (3) carve-out generic-drugs hatch-waxman-act induced-infringement patent-infringement skinny-label 1. When a generic drug label fully carves out a patented use, are allegations that the generic drugmaker calls its product a "generic version" and cit…
24A652 Hikma Pharmaceuticals USA Inc., et al. v. Amarin Pharma, Inc., et al. Federal Circuit 2024-12-31 Presumed Complete generic-drug hatch-waxman-act induced-infringement patent-infringement section-viii skinny-label Question not identified.
24-428 Edwards Lifesciences Corporation, et al. v. Meril Life Sciences Pvt. Ltd., et al. Federal Circuit 2024-10-16 Denied Amici (1)Response RequestedResponse WaivedRelisted (2) federal-circuit hatch-waxman-act patent-infringement regulatory-use safe-harbor statutory-interpretation Whether, under Hatch-Waxman's safe harbor, an infringing act is "solely for uses reasonably related" to the federal regulatory process, when the infri…
24-294 Norwich Pharmaceuticals Inc. v. Salix Pharmaceuticals, Ltd., et al. Federal Circuit 2024-09-13 Denied fda-approval generic-drugs hatch-waxman-act injunctive-relief patent-law statutory-interpretation Whether 35 U.S.C. § 271(e)(4)(A) requires courts to issue injunctive orders that are broader in scope than the underlying infringement, thereby delayi…
22-37 Teva Pharmaceuticals USA, Inc. v. GlaxoSmithKline LLC, et al. Federal Circuit 2022-07-13 Denied CVSGAmici (5)Relisted (3) active-inducement fda-approval generic-drug generic-drugs hatch-waxman-act inducement-doctrine patent-infringement skinny-label If a generic drug's FDA-approved label carves out all of the language that the brand manufacturer has identified as covering its patented uses, can th…